NCT01910506View on ClinicalTrials.gov

RDEA3170 AME Study

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

September 30, 2013

Study Completion Date

November 30, 2013

Conditions
Healthy
Interventions
DRUG

RDEA3170 10 mg

Trial Locations (1)

53704

Madison

Sponsors
All Listed Sponsors
lead

Ardea Biosciences, Inc.

INDUSTRY